The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (HGH) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (HGH) trades at $25.00 with AI Score 43/100 (Grade C). The Hartford Financial Services Group, Inc. Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for HGH: HGH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HGH against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
HGH: the 3 scored disciplines are evenly split.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (HGH) Financial Services Profile
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (HGH) represents a fixed/floating rate debt security within the insurance and financial services landscape. It provides investors exposure to The Hartford's creditworthiness, offering a blend of fixed income and potential yield adjustments based on prevailing interest rates.
What Is the Investment Thesis for HGH?
Investing in The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (HGH) offers exposure to a well-established player in the insurance and financial services sector. With a P/E ratio of 9.78 and a profit margin of 13.5%, the company demonstrates reasonable profitability. The dividend yield of 1.66% provides a steady income stream. Key value drivers include The Hartford's strong market position and diversified product offerings. Potential catalysts include favorable changes in interest rates, which could increase the yield on the floating rate portion of the debt. A potential risk is adverse changes in the insurance market, which could negatively impact The Hartford's financial performance.
Based on FMP financials and quantitative analysis
HGH Key Highlights
P/E ratio of 9.78 indicates a potentially undervalued investment relative to earnings.
- Profit margin of 13.5% reflects solid profitability within the financial services sector.
- Gross margin of 46.2% demonstrates efficient cost management and pricing strategies.
- Beta of 0.07 suggests low volatility compared to the overall market, indicating a relatively stable investment.
- Dividend yield of 1.66% provides a consistent income stream for investors.
Who Are HGH's Competitors?
HGH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| EACQ Easterly Acquisition Corp. | $10.44 | -0.10% | $2.19B | 47 |
| EZT Entergy Texas, Inc. | $25.22 | -0.08% | $1.17B | 46 |
| GATX GATX Corporation | $174.96 | -0.68% | $6.21B | 43 |
| GRND Grindr Inc. | $15.66 | +0.45% | $2.78B | 92 |
| LMHA Legg Mason, Inc. | $25.70 | -0.50% | $3.11B | 46 |
| BSV Vanguard Short-Term Bond ETF | $77.62 | -0.08% | $69.9B | 44 |
| AEH Aegon N.V. PRP CP SEC 6.375 | $25.67 | +0.00% | $52.5B | 46 |
| DWACW Digital World Acquisition Corp. | $23.15 | +26.02% | $864M | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HGH's Key Strengths?
Established brand with a long history.
- Diversified product portfolio.
- Strong distribution network.
- Solid financial performance.
What Are HGH's Weaknesses?
Exposure to cyclical insurance markets.
- Dependence on independent agents and brokers.
- Potential for large claims payouts.
- Vulnerability to regulatory changes.
What Could Drive HGH Stock Higher?
HGH catalyst: Potential changes in interest rates affecting the yield on the floating rate portion of the debt.
- Continued growth in the insurance and financial services markets.
- Strategic initiatives to expand product offerings and geographic reach.
What Are the Key Risks for HGH?
Adverse changes in the insurance market impacting financial performance.
- Economic downturns reducing demand for insurance products.
- Regulatory changes affecting the insurance industry.
- Competition from other insurance and financial services providers.
What Are the Growth Opportunities for HGH?
- Expansion of Digital Insurance Offerings: The Hartford can capitalize on the growing demand for digital insurance solutions by investing in technology and developing user-friendly online platforms. The digital insurance market is projected to reach $400 billion by 2027, offering a significant growth opportunity. This expansion would allow The Hartford to reach a wider customer base and improve customer satisfaction.
- Strategic Partnerships and Acquisitions: The Hartford can pursue strategic partnerships and acquisitions to expand its product offerings and geographic reach. The insurance industry is consolidating, creating opportunities for companies to acquire smaller players and enter new markets. A well-executed acquisition strategy could significantly boost The Hartford's revenue and market share.
- Focus on Personalized Financial Advice: As customer needs become more complex, The Hartford can focus on providing personalized financial advice to its clients. This includes offering tailored insurance and investment solutions based on individual circumstances. The market for personalized financial advice is growing rapidly, driven by increasing demand for retirement planning and wealth management services.
- Development of Innovative Insurance Products: The Hartford can differentiate itself from competitors by developing innovative insurance products that address emerging risks. This includes products that cover cyber threats, climate change, and other evolving challenges. Innovation in product development can attract new customers and enhance The Hartford's brand reputation.
- Enhancement of Data Analytics Capabilities: The Hartford can leverage data analytics to improve its underwriting, pricing, and claims management processes. By analyzing customer data, the company can better assess risk and offer more competitive pricing. Data analytics can also help The Hartford identify fraudulent claims and reduce costs. Investment in data analytics capabilities is crucial for maintaining a competitive edge in the insurance industry.
What Threats Does HGH Face?
- Intense competition in the insurance industry.
- Economic downturns affecting insurance demand.
- Rising interest rates impacting investment returns.
- Cybersecurity risks and data breaches.
What Are HGH's Competitive Advantages?
- Strong brand reputation built over 200 years.
- Extensive distribution network of independent agents and brokers.
- Diversified product offerings across insurance and financial services.
- Financial strength and stability reflected in high credit ratings.
What Does HGH Do?
The Hartford Financial Services Group, Inc. is a leading provider of insurance and financial services, including property and casualty insurance, group benefits, and mutual funds. Founded in 1810, the company has a long history of providing financial security and protection to individuals and businesses. Over the years, The Hartford has evolved from a fire insurance company to a diversified financial services organization. Today, The Hartford operates through a network of independent agents, brokers, and financial advisors, as well as through direct channels. The company's property and casualty insurance products include auto, home, and business insurance. Its group benefits offerings include life, disability, and accident insurance. The Hartford also offers a range of investment products, including mutual funds and annuities. The Hartford's commitment to innovation and customer service has helped it maintain a strong position in the competitive financial services industry. The company's financial strength and stability have earned it high ratings from major credit rating agencies.
What Products and Services Does HGH Offer?
- Provides property and casualty insurance to individuals and businesses.
- Offers group benefits, including life, disability, and accident insurance.
- Manages investment products, such as mutual funds and annuities.
- Distributes products through independent agents, brokers, and financial advisors.
- Provides risk management services to help clients mitigate potential losses.
- Offers specialty insurance products for specific industries and risks.
How Does HGH Make Money?
- Generates revenue from insurance premiums.
- Earns investment income from managing assets.
- Collects fees for providing financial advice and risk management services.
- Manages claims and pays out benefits to policyholders.
What Industry Does HGH Operate In?
The Hartford operates within the highly competitive insurance and financial services industry. The industry is characterized by evolving customer needs, technological advancements, and regulatory changes. The market is driven by factors such as economic growth, interest rates, and demographic trends. Key competitors include companies like EZT and GATX. The Hartford's diversified product offerings and strong brand reputation position it well to compete in this dynamic environment. The industry is experiencing growth in areas such as digital insurance and personalized financial advice.
Who Are HGH's Key Customers?
- Individuals seeking personal insurance coverage.
- Businesses requiring commercial insurance solutions.
- Employees participating in group benefits plans.
- Investors seeking financial products and services.
Key Financial Metrics
Return on equity for The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 stands at 22.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.7%, showing how much profit it generates from its asset base. HGH trades at a trailing price-to-earnings ratio of 9.08, below the Financial Services sector average of ~18x. Its free cash flow yield is 16.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 18.17 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 11.0%, the inverse of the P/E and a quick read on earnings relative to price.
HGH Valuation & Market Position
Relative to its peer group, HGH's quantitative score of 43/100 is below the peer average of 55/100.
Company Profile
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 operates in the Insurance - Diversified industry within the Financial Services sector. HGH has traded publicly since 2013.
HGH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Hartford's recent insider buying suggests confidence from those who know the company best. Community sentiment reflects optimism about Hartford's stability in the insurance sector. Positive market perception of Hartford's fixed income products is growing. Overall, the market sees Hartford as a safe haven during uncertain times.
- Hartford's DEB FIX/FLT 42 structure offers a predictable income stream, appealing to risk-averse investors. The community seems to appreciate the predictable nature of these securities. The market is recognizing the value of stable, fixed-income assets.
- Recent market trends favor established financial institutions like Hartford. The community is highlighting Hartford's long-standing reputation. The market is rewarding companies with a proven track record.
- Hartford's diversified insurance offerings mitigate risk, attracting bullish sentiment. Community discussions highlight the strength of this diversification. The market views diversified financials favorably.
Bear Case
- Rising interest rates could negatively impact the value of Hartford's fixed-income portfolio. Community discussions reflect concerns about interest rate sensitivity. The market is wary of fixed-income assets in a rising rate environment.
- Potential for increased regulatory scrutiny in the insurance industry is a concern. The community is discussing the potential impact of new regulations. The market is sensitive to regulatory changes in the financial sector.
- Economic uncertainty could lead to increased claims and reduced profitability for Hartford. Community sentiment reflects worries about economic downturns. The market is factoring in potential economic headwinds.
- Competition from fintech companies and disruptive insurance models poses a threat. Community debates acknowledge the challenge from new competitors. The market is watching how Hartford adapts to innovation.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
HGH Latest News
No recent news available for HGH.
HGH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HGH.
Price Targets
Wall Street price target analysis for HGH.
HGH MoonshotScore
What does this score mean?
The MoonshotScore rates HGH 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: None
CEO title
Unknown
Track Record: Unknown
What Investors Ask About The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (HGH) — Financial Services
What does the AI Score mean for HGH?
HGH holds an AI Score of 43/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 is a debt instrument issued by The Hartford, a major player in the insurance and financial services sector. As a fixed/floating rate debt …
What does The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 do?
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 represents a debt instrument issued by The Hartford. As a fixed/floating rate debt security, it provides investors with a blend of fixed income and potential yield adjustments based on prevailing interest rates.
What do analysts say about HGH stock?
As HGH is a debt instrument and not common stock, traditional analyst ratings do not apply. Investors should focus on credit ratings assigned by agencies like Moody's and Standard & Poor's to assess the creditworthiness of The Hartford. Key valuation metrics include the yield to maturity, credit spread, and duration of the debt.
What are the main risks for HGH?
The primary risk for HGH is credit risk, which is the risk that The Hartford may be unable to meet its debt obligations. This risk is influenced by factors such as the company's financial performance, industry conditions, and overall economic environment. Changes in interest rates can also impact the value of the debt.
What are the key factors to evaluate for HGH?
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (HGH) holds an AI score of 43/100 (low). Not financial advice.
How frequently does HGH data refresh on this page?
HGH's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven HGH's recent stock price performance?
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (HGH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand with a long history. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HGH overvalued or undervalued right now?
The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (HGH) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research HGH before investing?
Before investing in The Hartford Financial Services Group, Inc. DEB FIX/FLT 42 (HGH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for HGH, which may provide additional insights.
- Financial data is based on the most recent available information.